Voronoi Inc
KOSDAQ:310210
Voronoi Inc
Other
Voronoi Inc
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Other
-₩23m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Other
₩628.1B
|
CAGR 3-Years
88%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
19%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Other
-₩60.8m
|
CAGR 3-Years
28%
|
CAGR 5-Years
-75%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Other
-₩55.4m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Other
₩0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Voronoi Inc
Glance View
Voronoi, Inc. engages in the manufacture of novel kinase inhibitors and target protein degrader drugs. The company is headquartered in Incheon, Incheon. The company went IPO on 2022-06-24. The firm is principally engaged in the technology transfer of new drug candidates prior to electroclinical clinical trials. The firm is principally engaged in the research and development of kinase inhibitor as well as others. In addition, the Company is also engaged in the building and supply of new drug development platforms based on artificial intelligence (AI) and research results.
See Also
What is Voronoi Inc's Other?
Other
-23m
KRW
Based on the financial report for Dec 31, 2024, Voronoi Inc's Other amounts to -23m KRW.
What is Voronoi Inc's Other growth rate?
Other CAGR 1Y
98%
Over the last year, the Other growth was 98%.
